We investigated whether a freshwater clam (Corbicula fluminea) extract (FCE) could improve cholesterol metabolism and hepatic lipids accumulation in rats fed xenobiotics such as chloretone. Feeding chloretone resulted in hypercholesterolemia and fatty liver. An increase in serum cholesterol, high density lipoproteins (HDL) in particular, after intake of chloretone was observed. Serum cholesterol was decreased by supplementation with FCE. Accumulation of the hepatic lipids including triacylglycerol, cholesterol, and phospholipid was significantly suppressed by supplementation with FCE. The excretion of neutral and acidic sterols into the feces was enhanced by FCE. The hepatic gene expression of cholesterol 7alpha-hydroxylase was enhanced in rats fed a FCE-containing diet. Apolipoprotein A-I gene expression in the liver, which is a major apolipoprotein of HDL, was suppressed by FCE. These results demonstrated that FCE reduced cholesterol level and hepatic lipids in normal rats and hypercholesterolemic rats fed chloretone.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jf803308hDOI Listing

Publication Analysis

Top Keywords

hepatic lipids
16
rats fed
12
freshwater clam
8
clam corbicula
8
corbicula fluminea
8
fluminea extract
8
cholesterol level
8
level hepatic
8
lipids normal
8
normal rats
8

Similar Publications

Background: In the past few decades, selective serotonin reuptake inhibitors (SSRIs) became widely used antidepressants worldwide. Therefore, the adverse reactions of patients after SSRI administration became a public and clinical concern. In this study, we conducted a pharmacovigilance study using the Adverse Event Reporting System (FAERS) database of the US Food and Drug Administration.

View Article and Find Full Text PDF

Reducing off-target expression of mRNA therapeutics and vaccines in the liver with microRNA binding sites.

Mol Ther Methods Clin Dev

March 2025

Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55902, USA.

Lipid nanoparticles (LNPs) are often liver tropic, presenting challenges for LNP-delivered mRNA therapeutics intended for other tissues, as off-target expression in the liver may increase side effects and modulate immune responses. To avoid off-target expression in the liver, miR-122 binding sites have been used by others in viral and non-viral therapeutics. Here, we use a luciferase reporter system to compare different copy numbers and insertion locations of miR-122 binding sequences to restrict liver expression.

View Article and Find Full Text PDF

Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins.

Heliyon

January 2025

Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, Xinjiang, 830046, China.

Statins are widely used for treating lipid disorders and cardiovascular diseases. However, the therapeutic efficiency and adverse effects of statins vary among different patients, which numerous clinical and epidemiological studies have attributed to genetic polymorphisms in statin-metabolizing enzymes and transport proteins. The metabolic processes of statins are relatively complex, involving spontaneous or enzyme-catalyzed interconversion between more toxic lactone metabolites and active acid forms in the liver and bloodstream, influenced by multiple factors, including the expression levels of many metabolic enzymes and transporters.

View Article and Find Full Text PDF

Ya That Somdun (YTS) is a traditional Thai medicine composed of six herbs used as a strengthening tonic. Some of the herbs constituting YTS have antihyperlipidemic and anti-obesity activities. The objective of this study was to elucidate the antihyperlipidemic properties of YTS extract in rats with cholesterol suspension-induced hyperlipidemia.

View Article and Find Full Text PDF

Background And Aims: Alcohol Use Disorder (AUD) is a psychiatric disorder characterized notably by gut microbial dysbiosis and insufficient dietary fiber intake. This study aims to investigate the effect of dietary fiber placebo-controlled intervention in patients suffering from AUD during a three-week period of alcohol withdrawal, in order to discover microbial-derived metabolites that could be involved in metabolic and behavioral status.

Methods: A randomized, double-blind, placebo-controlled study was performed with 50 AUD patients supplemented with inulin (prebiotic dietary fiber) or maltodextrin (placebo) during 17 days.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!